Cargando…
Identification of Compound CB-2 as a Novel Late-Stage Autophagy Inhibitor Exhibits Inhibitory Potency against A549 Cells
Autophagy has been recognized as a stress tolerance mechanism that maintains cell viability, which contributes to tumor progression, dormancy, and treatment resistance. The inhibition of autophagy in cancer has the potential to improve the therapeutic efficacy. It is therefore of great significance...
Autores principales: | Liu, Zhihui, Zhang, Lu, Liu, Yachao, Zhang, Hanxiao, Chen, Jingxuan, Feng, Gaoqing, Yang, Peichang, Sha, Fangfang, Cui, Liuqing, Sun, Gangchun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8401303/ https://www.ncbi.nlm.nih.gov/pubmed/34440609 http://dx.doi.org/10.3390/life11080865 |
Ejemplares similares
-
CUR5g, a novel autophagy inhibitor, exhibits potent synergistic anticancer effects with cisplatin against non-small-cell lung cancer
por: Chen, Jingxuan, et al.
Publicado: (2022) -
CD44 connects autophagy decline and ageing in the vascular endothelium
por: Zhang, Lu, et al.
Publicado: (2023) -
Betulinaldehyde exhibits effective anti-tumor effects in A549 cells by regulating intracellular autophagy
por: Huang, Pan-hao, et al.
Publicado: (2023) -
Inhibitory role of puerarin on the A549 lung cancer cell line
por: Lang, Jie, et al.
Publicado: (2022) -
Andrographolide sodium bisulphite-induced inactivation of urease: inhibitory potency, kinetics and mechanism
por: Mo, Zhi-Zhun, et al.
Publicado: (2015)